HYTN Receives GMP Certificates for The United States, Bermuda and Israel
VANCOUVER, British Columbia, April 02, 2025 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” […]
ThreeD Capital Inc. Cancels Upcoming Annual and Special Meeting of Shareholders
TORONTO, April 02, 2025 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture […]
Vital Battery Metals Announces Private Placement
VANCOUVER, British Columbia, April 02, 2025 (GLOBE NEWSWIRE) — Vital Battery Metals Inc. (“Vital” or the “Company”) (CSE: VBAM | […]
American Tungsten Corp. Joins The Critical Mineral Institute
Vancouver, BC, April 02, 2025 (GLOBE NEWSWIRE) — American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is […]
Green Thumb Industries to Hold First Quarter 2025 Earnings Conference Call on May 7, 2025
CHICAGO and VANCOUVER, British Columbia, April 02, 2025 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: […]
Global Helium Corp. Announces Sale of Standing Well and Lands in Montana
CALGARY, Alberta, April 02, 2025 (GLOBE NEWSWIRE) — Global Helium Corp. (“HECO” or the “Company”) (CSE: HECO, OTC: HECOF) is […]
Planet 13 Opens New Dispensary in Orange Park, FL, Serving Jacksonville Patients
LAS VEGAS, April 02, 2025 (GLOBE NEWSWIRE) — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the […]
Multiple Pay Zones Discovered in Successful Drill Program
VANCOUVER, B.C, April 02, 2025 (GLOBE NEWSWIRE) — BGX – Black Gold Exploration Corp. (the “Company” or “BGX) (CSE: BGX) […]
Cannabix Technologies to Attend U.S. National Drug and Alcohol Conference to Market Marijuana Breath Test
VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the […]
Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment
The clinical trial is designed to evaluate the safety, tolerability and efficacy of Clearmind’s innovative, psychedelic-derived, MEAI-based compound in individuals […]
